What is the CURE.CN share price today?

This page shows the latest available Biocure Technology Inc. (CURE.CN) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Biocure Technology Inc. listed?

Biocure Technology Inc. trades on the Canadian Securities Exchange under the symbol CURE.CN, ISIN CA09075T1075.

How large is Biocure Technology Inc.?

Its market capitalisation is approximately 408.02K CAD, based on the latest available price and share count from our data provider.

Canadian Securities Exchange (CSE) · CURE.CN · ISIN CA09075T1075

Biocure Technology Inc.

No trading activity has been reported for this listing since July 12, 2024. It may be delisted, halted or inactive.

0.0050 CAD

July 12, 2024

Biocure Technology Inc. (CURE.CN) trades on the Canadian Securities Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 408.02K CAD. Its ISIN is CA09075T1075. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Key facts

Exchange

Canadian Securities Exchange (CSE)

ISIN

CA09075T1075

Sector

Healthcare

Industry

Biotechnology

Country

Market cap

408.02K CAD

Previous close

0.05 CAD

Day range

0.01 – 0.01

52-week range

0.01 – 0.04

Volume

Asset type

Equity

About Biocure Technology Inc.

Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.

Company website

Frequently asked

What is the CURE.CN share price today?: This page shows the latest available Biocure Technology Inc. (CURE.CN) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Biocure Technology Inc. listed?: Biocure Technology Inc. trades on the Canadian Securities Exchange under the symbol CURE.CN, ISIN CA09075T1075.
How large is Biocure Technology Inc.?: Its market capitalisation is approximately 408.02K CAD, based on the latest available price and share count from our data provider.

All Biocure Technology Inc. data comes from exchange and provider feeds for the Canadian Securities Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.